Analysten nachrichten

Intellipharmaceutics Signs an Exclusive License & Supply Agreement with Taro Pharmaceuticals Inc. for Desvenlafaxine Extended-Release Tablets

External page is loading, the page should display in a few seconds..

    Follow @AnalystenNews on Twitter!